Skip to main content

Table 2 Alpha defensin levels according to clinical manifestations of systemic sclerosis

From: Serum defensin levels in patients with systemic sclerosis

Clinical manifestations

No involvement

Involvement present

P values

Interstitial lung disease

430 [140–595] (n = 22)

684 [324–1152] (n = 20)

0.04*

Pulmonary hypertension

503 [139–888] (n = 31)

624 [300–991] (n = 11)

0.4

Raynaud’s phenomenon

512 (n = 1)

564 [157–890] (n = 41)

0.95

Telangiectasia

621 [388–894] (n = 22)

498 [135–879] (n = 20)

0.29

Digital Ulcer

583 [165–938] (n = 26)

529 [164–813] (n = 16)

0.56

Esophageal Involvement

588 [352–890] (n = 29)

506 [124–933] (n = 13)

0.34

  1. Values represent median with 25–75 percentiles in square brackets and the number of patients in parentheses
  2. *p value <0,05